Matityahu M. Fridkin
#153,260
Most Influential Person Now
Matityahu M. Fridkin's AcademicInfluence.com Rankings
Matityahu M. Fridkinphilosophy Degrees
Philosophy
#8562
World Rank
#11969
Historical Rank
Logic
#5592
World Rank
#7001
Historical Rank
Matityahu M. Fridkinbiology Degrees
Biology
#11611
World Rank
#15016
Historical Rank
Microbiology
#662
World Rank
#731
Historical Rank
Immunology
#756
World Rank
#778
Historical Rank
Download Badge
Philosophy Biology
Matityahu M. Fridkin's Degrees
- Doctorate Medicine Stanford University
Why Is Matityahu M. Fridkin Influential?
(Suggest an Edit or Addition)Matityahu M. Fridkin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. (2002) (351)
- Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. (1980) (306)
- All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance (1990) (283)
- Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos (1993) (275)
- Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbb protein (1985) (247)
- Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes (2003) (199)
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun* (1998) (192)
- Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. (1999) (179)
- Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. (1996) (176)
- Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides (1995) (174)
- Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. (1997) (174)
- CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1997) (162)
- An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. (1991) (151)
- Insulin-like effects of vanadium: basic and clinical implications. (2000) (148)
- CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1994) (145)
- Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. (2000) (140)
- Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. (1998) (127)
- A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. (1993) (124)
- Gonadotropin-releasing hormone in milk. (1977) (122)
- Augmentation of the antibacterial activity of magainin by positive-charge chain extension (1992) (120)
- Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. (1994) (119)
- The Binding Site of Acetylcholine Receptor as Visualized in the X-Ray Structure of a Complex between α-Bungarotoxin and a Mimotope Peptide (2001) (116)
- Enzymic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissue. (1974) (113)
- NAP, a Femtomolar-Acting Peptide, Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death (2002) (113)
- Adhesion of human platelets to serum amyloid A. (2002) (111)
- Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit. (1986) (110)
- Tuftsin: its chemistry, biology, and clinical potential. (1989) (108)
- Vasoactive intestinal peptide potentiates sexual behavior: Inhibition by novel antagonist (1989) (104)
- Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes. (1977) (102)
- A Synthesis of Cyclic Peptides Utilizing High Molecular Weight Carriers (1965) (102)
- Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. (1996) (100)
- Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. (1995) (100)
- Production and characterization of an antiserum to synthetic gonadotropin-releasing hormone. (1973) (98)
- Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. (1996) (97)
- Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells. (1978) (90)
- IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. (1998) (86)
- Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome. (1985) (85)
- Resistance to enzymic degradation of LH-RH analogues possessing increased biological activity. (1977) (85)
- The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. (2000) (78)
- Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat (1991) (76)
- Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. (1997) (74)
- Prolonging the Action of Protein and Peptide Drugs by a Novel Approach of Reversible Polyethylene Glycol Modification* (2004) (74)
- N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity (2001) (73)
- Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein. (1994) (73)
- Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk. (2005) (72)
- Structure-function studies of amphiphilic antibacterial peptides. (1993) (72)
- The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. (2007) (71)
- Suppression of gonadotropin secretion and prevention of ovulation in the rat by antiserum to synthetic gonadotropin-releasing hormone. (1973) (70)
- Antibodies to synthetic peptides as probes for the binding site on the alpha subunit of the acetylcholine receptor. (1985) (68)
- New useful reagents for peptide synthesis. Insoluble active esters of polystyrene-bound 1-hydroxybenzotriazole. (1975) (67)
- Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. (2009) (67)
- Use of Polymers as Chemical Reagents. I. Preparation of Peptides (1966) (66)
- Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. (2002) (65)
- Degradation of gonadotropin-releasing hormones in the gilthead seabream, Sparus aurata. II. Cleavage of native salmon GnRH, mammalian LHRH, and their analogs in the pituitary, kidney, and liver. (1990) (63)
- Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease. (1997) (63)
- Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1. (1981) (62)
- A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes (1991) (62)
- VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress (2000) (61)
- The gene for the neuropeptide gonadotropin-releasing hormone is expressed in the mammary gland of lactating rats. (1994) (60)
- The effect of Tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes. (1975) (60)
- Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period. (2004) (60)
- Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design. (1999) (59)
- From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP (2007) (58)
- Use of polymers as chemical reagents. II. Synthesis of bradykinin. (1968) (58)
- A β-hairpin structure in a 13-mer peptide that binds α-bungarotoxin with high affinity and neutralizes its toxicity (2001) (57)
- Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes. (1978) (56)
- A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. (2004) (56)
- Decreased tuftsin concentrations in patients who have undergone splenectomy. (1977) (56)
- High levels of vasoactive intestinal peptide in human milk. (1985) (56)
- Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. (1998) (55)
- Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in mice (2005) (53)
- Peptides generated from C-reactive protein by a neutrophil membrane protease. Amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxis. (1990) (52)
- Radioimmunoassay of the phagocytosis‐stimulating peptide tuftsin in normal and splenectomized subjects (1977) (51)
- Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. (1999) (51)
- Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction. (1976) (50)
- VIP-related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells (2000) (49)
- Prolonging the half-life of human interferon-α2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-α2 (2001) (49)
- Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment. (1994) (49)
- Degradation of gonadotropin-releasing hormones in the gilthead seabream, Sparus aurata. I. Cleavage of native salmon GnRH and mammalian LHRH in the pituitary. (1990) (47)
- Novel therapeutic compound tuftsin–phosphorylcholine attenuates collagen‐induced arthritis (2016) (46)
- Modulation of human neutrophil function by C-reactive protein. (1987) (46)
- Angiotensin 1-7 as Means to Prevent the Metabolic Syndrome (2013) (46)
- VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells (2001) (45)
- Design and synthesis of peptides that bind α-bungarotoxin with high affinity (2001) (43)
- Thiolysis of dinitrophenylimidazoles and its use during synthesis of histidine peptides. (1970) (43)
- Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis. (1996) (42)
- Degradation of gonadotropin‐releasing hormone by anterior pituitary enzymes (1981) (42)
- 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs. (1996) (42)
- Novel breast‐tumor‐associated MUC1‐derived peptides: Characterization in Db−/− × β2 microglobulin (β2m) null mice transgenic for a chimeric HLA‐A2.1/Db‐β2 microglobulin single chain (2000) (41)
- Vasoactive intestinal peptide: a growth promotor in neuroblastoma cells (1993) (40)
- Immunoreactive and biologically active somatostatin in human and sheep milk. (1985) (40)
- Comparative structure-activity studies on mammalian [Arg8] LH-RH and chicken [Gln8] LH-RH by fluorimetric titration. (1983) (39)
- Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth (1999) (38)
- Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen. (1995) (38)
- Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine. (2015) (37)
- A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. (1997) (37)
- Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. (2002) (37)
- Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor (1986) (37)
- L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo. (1999) (37)
- Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues. (1981) (37)
- The Binding Site of Acetylcholine Receptor (2003) (36)
- Reversible pegylation of insulin facilitates its prolonged action in vivo. (2008) (36)
- A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model. (1992) (35)
- Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease. (2015) (35)
- Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin. (2005) (34)
- VIP analogues inhibit small cell lung cancer growth (1992) (33)
- Structural features of luliberin (luteinising hormone-releasing factor) inferred from fluorescence measurements. (1976) (33)
- SYNTHESES AND POLYMERIZATION OF α-TRIMETHYLSILYL ACRYLIC MONOMERS (1963) (32)
- Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators. (2000) (32)
- Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. (1992) (32)
- Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection. (1999) (32)
- Binding of human serum amyloid P component (hSAP) to human neutrophils. (1994) (31)
- Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas. (1997) (30)
- (Stearyl, Norleucine17)VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells. (1997) (30)
- Immune Response of SLE Patients to Peptides Based on the Complementarity Determining Regions of a Pathogenic Anti-DNA Monoclonal Antibody (2000) (30)
- Peptide synthesis by means of tert-butyloxycarbonylamino acid derivatives of poly(ethylene-co-N-hydroxymaleimide). (1972) (30)
- A novel approach for a water-soluble long-acting insulin prodrug: design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin. (2000) (29)
- Neopeptide Antibiotics That Function as Opsonins and Membrane-Permeabilizing Agents for Gram-Negative Bacteria (2005) (28)
- Pneumococcal Capsular Polysaccharide Is Immunogenic When Present on the Surface of Macrophages and Dendritic Cells: TLR4 Signaling Induced by a Conjugate Vaccine or by Lipopolysaccharide Is Conducive1 (2008) (28)
- Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin. (2008) (28)
- Synthesis and biological activity of tuftsin and of [O = C Thr1]-tuftsin. A novel synthetic route to peptides containing N-terminal L -O = C Thr and L - O = C Ser residues. (2009) (28)
- Studies on the enzymic degradation of luteinizing hormone releasing hormone by rat pituitary plasma membranes. (1981) (28)
- On the Synthesis of Naphthoquinonyl Heterocyclic Amino Acids (1996) (27)
- Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites (1997) (27)
- New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin. (1999) (27)
- Decreased serum tuftsin concentrations in sickle cell disease. (1980) (26)
- Toxicology and Antitumor Activity of Tuftsin a (1983) (26)
- Tuftsin‐AZT conjugate: potential macrophage targeting for AIDS therapy (2005) (26)
- Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity and mimic the three-dimensional structure of the binding-site of acetylcholine receptor. (2002) (25)
- Growth hormone releasing factor-like immunoreactivity in human milk. (1986) (24)
- Anti-acetylcholine receptor response achieved by immunization with a synthetic peptide from the receptor sequence. (1984) (24)
- Peptides related to the calcium binding domains II and III of calmodulin. Synthesis and calmodulin-like features. (2009) (24)
- Detection of mRNAs containing regulatory peptide coding sequences using synthetic oligodeoxynucleotides (1984) (24)
- New Technologies to Prolong Life-time of Peptide and Protein Drugs In vivo (2007) (24)
- Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism. (2000) (24)
- Spectral studies with histidyl-tryptophan peptides. (1969) (23)
- Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamus (2008) (23)
- Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells. (1993) (23)
- Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice (2017) (23)
- Antibodies directed against phosphothreonine residues as potent tools for studying protein phosphorylation. (1989) (23)
- Combined Local Blood–Brain Barrier Opening and Systemic Methotrexate for the Treatment of Brain Tumors (2015) (23)
- β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome. (2011) (22)
- The molecular and cellular basis of exostosis formation in hereditary multiple exostoses (2008) (22)
- An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases. (2000) (22)
- Receptor-mediated endocytosis of tuftsin by macrophage cells. (1984) (22)
- (N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines. (1999) (22)
- Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide. (2008) (21)
- Neuropeptides and Neuronal Survival: Neuroprotective Strategy for Alzheimer's Disease a (1997) (21)
- The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. (2006) (21)
- Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis (1998) (21)
- Archaebacterial and eukaryotic proteasomes prefer different sites in cleaving gonadotropin-releasing hormone (1995) (21)
- Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability (2008) (20)
- Monofunctional substrates of polynucleotide phosphorylase. The monoaddition of 2'(3')-O-isovaleryl-nucleoside diphosphate to an initiator oligonucleotide. (1971) (20)
- Deoxyoligonucleotide synthesis using a new phosphate protecting group. (1973) (20)
- Tuftsin, Thr-Lys-Pro-Arg (1981) (20)
- Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in an in Vitro Model of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins* (2012) (20)
- Effect of serum amyloid A, HDL-apolipoprotein, on endothelial cell proliferation. Implication of an enigmatic protein to atherosclerosis. (1996) (19)
- Hypothalamic hormones in milk. (1991) (19)
- Tuftsin analogs for probing its specific receptor site on phagocytic cells. (1982) (19)
- Studies toward the biosynthesis of vasoactive intestinal peptide (VIP) (1984) (19)
- Inhibition of human neuroblastoma growth by a specific VIP antagonist (2007) (18)
- Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2. (2001) (18)
- PACAP hybrid: a new PACAP receptor antagonist. (1997) (18)
- A VIP hybrid antagonist: From developmental neurobiology to clinical applications (1995) (17)
- C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation. (1992) (17)
- Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain. (2000) (17)
- A new route to polyamino acids containing histidine. (1971) (17)
- Altered Peptide Ligands of a Myasthenogenic Epitope as Modulators of Specific T‐Cell Responses (1996) (17)
- The use of polymeric carriers in the synthesis of cyclic peptides containing s s bonds abstract (1968) (16)
- Mapping of the cAMP‐dependent phosphorylation sites on the acetylcholine receptor. (1986) (16)
- Structure-activity relationships of luliberin substituted at position 8. (1976) (16)
- Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity. (2001) (16)
- Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives. (1987) (16)
- Novel naphthoquinonyl derivatives: Potential structural components for the synthesis of cytotoxic peptides (1996) (16)
- A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice. (2000) (16)
- Helminth-Based Product and the Microbiome of Mice with Lupus (2019) (16)
- Structure activity relationship study of polymyxin B nonapeptide. (2000) (15)
- Neuropeptide receptor transcripts are expressed in the rat clitoris and oscillate during the estrus cycle in the rat vagina (2005) (15)
- Delivery of neuropeptides from the periphery to the brain: studies with enkephalin. (2010) (15)
- Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role. (2009) (15)
- Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. (2010) (15)
- A photolabile protecting group for the phenolic hydroxyl function of tyrosine. (2009) (14)
- Use of Nim-t-Butyloxycarbonyl in the Synthesis of Poly-L-histidine (1971) (14)
- Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. (1999) (14)
- Generation and use of antibodies to phosphothreonine. (1991) (14)
- N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative. (2002) (14)
- A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes. (2002) (14)
- Thiolysis of O-2,4-dinitrophenyltyrosines. Spectrophotometric monitoring of the reaction and its use in peptide synthesis. (1977) (14)
- Generation of specific antiserum to thyrotropin releasing‐hormone and its use in a radioimmunoassay (1976) (14)
- Poly(L‐leucyl‐L‐ornithyl‐L‐leucine) and its Guanidization Product: Synthesis and Antibacterial Activity (1969) (14)
- Characterization of neutrophil‐mediated degradation of human C‐reactive protein and identification of the protease (1992) (13)
- Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms. (1987) (13)
- The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure. (2003) (13)
- Acquired Tuftsin Deficiency (1983) (13)
- A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo (2001) (12)
- Tuftsin–phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model (2018) (12)
- Poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid). II. Catalysis of p‐nitrophenyl acetate hydrolysis (1978) (12)
- Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group. (2009) (12)
- Modulation of prostaglandin I2 production from bovine aortic endothelial cells by serum amyloid A and its N-terminal tetradecapeptide. (1996) (12)
- The 2,4-dinitrophenyl group for protection of hydroxyl function of tyrosine during solid-phase peptide synthesis. (2009) (12)
- Functionalization of polystyrene. III. Synthesis of polymeric thiol reagents (1982) (12)
- Sequential degradation of the neuropeptide gonadotropin‐releasing hormone by the 20 S granulosa cell proteasomes (1994) (12)
- Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone. (2001) (12)
- Structure-function relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase. (2001) (12)
- Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis (2018) (12)
- Synthesis of poly‐L‐asparagine and poly‐L‐glutamine (1969) (11)
- Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production. (2009) (11)
- Inhibition by tuftsin of Rauscher virus leukemia development in mice. (1983) (11)
- A Fatty Neuropeptide: Potential Drug for Noninvasive Impotence Treatment in a Rat Model (1993) (11)
- Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity. (1986) (11)
- Nonaqueous titrimetric determination of active esters of amino acids and peptide derivatives. (1970) (11)
- Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group. An approach towards a general deprotection scheme in peptide synthesis. (1990) (10)
- Protection Against Developmental Deficiencies by a Lipophilic VIP Analogue (1998) (10)
- ‘1-8 interferon inducible gene family’: putative colon carcinoma-associated antigens (2007) (10)
- Use of trityl- and -naphthylcarbamoylcellulose derivatives in oligonucleotide synthesis. (1973) (10)
- Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 11. Enzymatic joining to form the total DNA duplex. (1976) (10)
- Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivatives. (1987) (10)
- Design and synthesis of potent hexapeptide and heptapeptide gonadotropin-releasing hormone antagonists by truncation of a decapeptide analogue sequence. (2000) (10)
- Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: use of overlapping peptide sequences to identify a unique inhibitor. (2009) (9)
- On the function of arginine in luteinizing hormone‐releasing hormone (1977) (9)
- Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity. (1983) (9)
- Synthesis and catalytic properties of the heptapeptide L-seryl-L-prolyl-L-cysteinyl-L-steryl-alpha-L-glutamyl-L-threonyl-L-tyrosine. (1974) (9)
- Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines. (1990) (9)
- Insulin-like Effects of Vanadium; Reviewing In Vivo and In Vitro Studies and Mechanisms of Action (1998) (8)
- Use of Polymeric Reagents in the Synthesis of Linear and Cyclic Peptides (1973) (8)
- Toxicology and antitumor activity of tuftsin in mice. Abstr. (1981) (8)
- Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin. (2012) (8)
- Synthesis and bioactivity of fatty acid-conjugated GnRH derivatives. (1999) (8)
- [2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug. (2003) (8)
- Suspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats. (2003) (8)
- Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor-α by human T-lymphocytes (1998) (8)
- Novel extended and branched N-terminal analogs of VIP (2006) (7)
- Degradation of Luteinizing Hormone-Releasing Hormone by Rat Pituitary Plasma Membrane Associated Enzymes (1984) (7)
- Structure-activity studies of reduced-size gonadotropin-releasing hormone agonists derived from the sequence of an endothelin antagonist. (2000) (7)
- Polymeric 2-mercaptopyridine and 2-mercapto-nitrobenzene derivatives. New reagents for peptide synthesis. (2009) (7)
- Growth hormone releasing factor and somatostatin concentrations in the milk of lactating women (1988) (7)
- NMR studies of H-D exchange of α-CH group of amino acid residues in peptides (1970) (7)
- ANTINEOPLASTIC, IMMUNOGENIC AND OTHER EFFECTS OF THE TETRAPEPTIDE TUFTSIN: A NATURAL MACROPHAGE ACTIVATOR (1983) (6)
- Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 5. Synthesis of the deoxyribopolynucleotide segments representing the nucleotide sequence 71-103. (1976) (6)
- The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses. (2003) (6)
- Development of VIP Agonists and Antagonists with Tissue and Receptor Specificity: Effects on Behavioral Maturation, Sexual Function, and the Biologic Clock a (1996) (6)
- Mast cell adhesion to extracellular matrix: local effects of acute phase reactants. (1997) (6)
- Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin. (1990) (6)
- Purification of the gonadotropin-releasing hormone-degrading enzyme by affinity chromatography. (1977) (6)
- INFLUENCE OF THE SYNTHETIC PENTAPEPTIDE LAsp‐Ser‐Asp‐Pro‐Arg ON THE DIRECT AND INDIRECT MAST CELL DEGRANULATION INDUCED BY REAGINIC ANTIBODIES (1977) (6)
- Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G. (2009) (6)
- The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis. (2019) (5)
- The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti- β2GPI Abs induced by common bacteria (2001) (5)
- Annals of the New York Academy of Sciences. Volume 419. Antineoplastic, Immunogenic and Other Effects of the Tetrapeptide Tuftsin: A Natural Macrophage Activator Held at New York on 16-17 February 1983, (1983) (5)
- Novel analogs of VIP with multiple C-terminal domains (2007) (5)
- Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis (2021) (5)
- Localization of growth hormone-releasing hormone in the human hypothalamus and pituitary stalk. (1986) (5)
- Human peritoneal macrophage activity is increased by tuftsin. (1989) (5)
- Design and Synthesis of Peptides That Bind α-Bungarotoxin with High Affinity and Mimic the Three-Dimensional Structure of the Binding Site of Acetylcholine Receptor (2003) (5)
- Synthetic Pathways to Tuftsin and Radioimmunoassay (1983) (5)
- A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs. (2000) (5)
- A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells. (2000) (5)
- Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors. (2000) (4)
- Introduction of the dansyl group into histidine and tyrosine residues in peptides and proteins. (1985) (4)
- Poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid). I. Synthesis (1977) (4)
- PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR SUBTYPES IN RAT TISSUES: INVESTIGATION OF RECEPTOR BINDING, A NOVEL VIP RECEPTOR ANTAGONIST AND CHEMICAL CROSS-LINKING (1994) (4)
- Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion. (1988) (4)
- Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions. (2019) (4)
- Detection of peptide active esters by thin-layer chromatography. (1970) (4)
- Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro. (1989) (4)
- The hydrolysis of p-nitrophenylacetate in water. Mechanism and method of measurement. (1974) (3)
- Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamus (2008) (3)
- Intranasal Delivery of Bioactive Peptides or Peptide Analogues Enhances Spatial Memory and Protects Against Cholinergic Deficits (2001) (3)
- Mediators of Cellular Immunity (1979) (3)
- Conformational changes of poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid) in solution. Transition pathways and conformational intermediates (1979) (3)
- Polymyxin B and Related Cyclic Peptides Facilitate Leanness and Reduce Fat Mass and Triglyceride Content in Ageing Rats: Potential Prototype Drugs Against Obesity (2006) (3)
- Retracted Correction: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (1998) (3)
- Potential use of tuftsin in treatment of candida peritonitis in a murine model. (1989) (3)
- Synthesis, biological activity and resistance to enzymic degradation of luteinizing hormone—releasing hormone analogues modified at position 7 (1981) (3)
- A study of extracellular matrix-cell adhesion peptidic epitopes related to human serum amyloid A (SAA) (1999) (2)
- Synthetic peptide approach to the analysis of kinase activities of avian EGF receptor and v-erbB protein. (1985) (2)
- Studies on the activity of phorbol myrystate acetate on the human polymorphonuclear leukocytes (1979) (2)
- Detection of aromatic amino acid derivatives on thin-layer chromatograms by various electron acceptors. (1968) (2)
- The detection of peptide hydrazides on thin-layer chromatograms. (1970) (2)
- Tuftsin Receptors a (1983) (2)
- FACILE THIOLYTIC REMOVAL OF THE O-NITROPHENYLSULFENYL AMINO-PROTECTING GROUP (1979) (2)
- Thiolysis of Nim-2,4-dinitrophenyl-histidine peptides with 2-mercaptoethanol. An explannation for the pH optimum. (2009) (2)
- Synthesis and biological activity of [L‐hydroxyproline]3‐tuftsin analogue and its α‐ or β‐O‐D‐glucosylated derivatives (2009) (2)
- Protection against developmental and learning impairments in apolipoprotein e-deficient mice by activity-dependent femtomolar-acting peptides (1997) (2)
- SYNTHESIS OF STABLE SPIROOXYPHOSPHORANES : POTENTIAL PROMOTERS OF CATALYTIC ANTIBODIES (1996) (2)
- On the role of tryptophan in luteinizing-hormone-releasing hormone (luliberin). (1977) (2)
- Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations (2016) (2)
- Immunostimulation by an Ig derived tetrapeptide, tuftsin (1979) (1)
- Degradation of C-reactive protein (CRP) by neutrophil lysosomal enzymes generates peptidic neutrophil modulators (1991) (1)
- Potentiating vanadium-evoked glucose metabolism by novel hydroxamate derivatives (2002) (1)
- The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti-β2GPI antibodies induced by common bacteria (2003) (1)
- Toward mechanized peptide synthesis via polymeric reagents approach (1977) (1)
- (4-Hydroxy-3-nitro)benzylated polystyrene. An improved polymeric nitrophenol derivative for peptide synthesis. (1974) (1)
- Establishing the principle of reversibility in peptide/protein and small-molecule therapy. (2012) (1)
- Blockade of VIP function in early mouse embryo induces severe microcephaly (1994) (1)
- Enzymatic processing of serum proteins: A route to peptides associated with host defense (1993) (1)
- Lipophilic vasoactive intestinal peptide: Potential drug for non-invasive impotence treatment (1993) (1)
- Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006 (2006) (1)
- Tumor-Associated Antigen Peptides as Anti-Metastatic Vaccines (2004) (1)
- Tuftsin-THF-gamma 2 chimeric peptides: potential novel immunomodulators. (1997) (1)
- Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 4. Synthesis of deoxyribopolynucleotide segments corresponding to the nucleotide sequence 47-78. (1976) (1)
- Proteolysis of human C-reactive protein by neutrophil-derived lysosomal enzymes generates peptides which modulate neutrophil function: Implication to the anti-inflammatory mechanism (1995) (1)
- NMR studies of H-D exchange of alpha-CH group of amino acid residues in peptides. (1970) (1)
- Preventive Treatment of Alzheimer’s Disease (1998) (1)
- Mercuration of tryptophan in luteinizing hormone-releasing hormone. (1978) (1)
- l-Glutamic Acid γ-Monohydroxamate (1999) (1)
- Pharmaceutical VIP: Prospects and Problems (1999) (1)
- VIP, novel proteins and peptide-mediated neuronal survival (2002) (0)
- Tuftsin Analogues: Synthesis, Structure-Function Relationships, and Im- plications for Specificity of Tuftsin′s Bioactivity. (1987) (0)
- Synthesis of Naphthoquinonyl Heterocylic Amino Acids. (1997) (0)
- Human serum amyloid P component (hSAP): Binding to and degradation by human polymorphonuclear leukocytes (1994) (0)
- P277 peptide analogs and pharmaceutical compositions comprising them for the treatment or diagnosis of diabetes. (1995) (0)
- Vip-related peptides for treatment of sexual dysfunction in women (2001) (0)
- Peptide synthesis. (1974) (0)
- Luliberin analogues exhibiting a cytotoxic effect on tumor cells in vitro (2006) (0)
- Poly(L-histidyl-L-alanyl-alpha-L-glutamic acid). I. Synthesis. (1977) (0)
- 3. The binding site for -bungarotoxin in the acetylcholine receptor: from synthetic peptides to solution and crystal structure (2003) (0)
- medicinal materials and Long-acting drug containing them (1997) (0)
- STRUCTURE ACTIVITY RELATIONSHIP STUDY OF POLYMYXIN B NONAPEPTIDE 1 (0)
- Serum Amyloid A Complexed with Extracellular Matrix Induces the Secretion of Tumor Necrosis Factor-α by human T-lymphocytes (2004) (0)
- SLE and other connective tissue diseases (animal models) (PP-017) (2010) (0)
- Abraham Patchornik — a scientist, a teacher, a friend (1994) (0)
- Development of Improved GNH Analogs for Controlled Reproduction of Sparus aurata in Farming Conditions (1985) (0)
- Gene therapy and peptide therapy of tumor metastasis (2007) (0)
- Modified VIP derivatives and pharmaceutical compositions containing them (1992) (0)
- Leukocyte Elastase and Migration by IL-2 Peptides Generated by Adherence Extracellular Matrix: Inhibition of IL-2 Induces T Cell Adherence to (1998) (0)
- Human and Murine β-Defensin-Derived Peptides Induce Rapid Mobilization Of Murine Hematopoietic Stem and Progenitor Cells Via Activation Of CXCR4 Signaling and CXCL12 Release (2013) (0)
- Inhibition of human leukocyte elastase and cathepsin G by extended peptides and subunits derived from human C-reactive protein (2004) (0)
- Organic polymeric reagents and methods for their preparation (1974) (0)
- Polymeric reagent synthesis of luteinizing hormone-releasing hormone (1977) (0)
- A study of extracellular matrix-cell adhesion peptidic epitopes related to human serum amyloid A (SAA) (2004) (0)
- Rapid separation of synthetic oligonucleotide mixtures on aromatic cellulose derivatives. (1974) (0)
- VIP, novel proteins and neuronal survival (2001) (0)
- 317 Immobilized serum amyloid A (SAA) induces mast cell (MC) adhesion to extracellular matrix (ECM) (1996) (0)
- Identification of Ser 153 in ICL2 of the GnRH receptor as a phosphorylation–independent site for inhibition of Gq coupling (2005) (0)
- Helminthes Derivative for Treating Acute and Chronic Colitis in Mice Models (2017) (0)
- New derivative of vasoacitive intestinal peptide (1992) (0)
- POLYMERIC 2-MERCAPTOPYRIDINE AND 2-MERCAPTO-NITROBENZENE DERIVATIVES. NEW REAGENTS FOR PEPTIDE SYNTHESIS (1981) (0)
- This information is current as by Lipopolysaccharide Is Conducive Signaling Induced by a Conjugate Vaccine or Macrophages and Dendritic Cells : TLR 4 ofImmunogenic When Present on the Surface Pneumococcal Capsular Polysaccharide Is Eisenbach (2008) (0)
- The Design, Synthesis, and Biological Evaluation of VIP and VIP Analogs (2008) (0)
- Polymeric organic reagents, particularly for organic syntheses, for the separation of metals, for ion-exchange and for scavenging aldehydes, and processes for their preparation (1975) (0)
- Actives prolonged effect and pharmaceutical composciones including them. (1997) (0)
- Peptides related to serum amyloid A (SAA) mediated cell adhesion: Implication to the physiological function of SAA (1993) (0)
- Structure and expression of the vasoactive intestinal peptide (VIP) gene (1985) (0)
- Cell Function-Associated Antigen Mediator of the Inhibitory Action of the Mast-Phosphatase Is the Main ′ Polyphosphate 5 SH 2 Domain-Containing Inositol (2001) (0)
- Potentiating vanadium-evoked glucose metabolism by novel hydroxamate derivatives (2004) (0)
- Modelins: A family of antibacterial computer-designed peptides (1993) (0)
- Highly active VIP - antagonists (1995) (0)
- Proteolysis of acute phase proteins: Implication to the anti-inflammatory response (1992) (0)
- Mechanisms controlling differentiation and function of antigen-presenting macrophages. (1982) (0)
- Novel magainin analogues: Structure-activity relationship (1991) (0)
- Biological activities of Polymyxin B nonapeptide analogs (2002) (0)
- A possible regulatory relationship exists between tuftsin and C-reactive protein (1993) (0)
- p277 PEPTIDE ANALOG, PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT AND DIAGNOSIS OF DIABETES (1995) (0)
- VIP: Design and synthesis of novel analogs and elucidating potential mechanisms affecting sexual function (2006) (0)
- Acceleration of apoptotic cells clearance by macrophages upon exposure to serum amyloid P component and its synthetic derivates (2005) (0)
- RECEPTORS FOR TUFTSIN ON PLASMA MEMBRANES OF MACROPHAGES AND MACROPHAGE HYBRIDOMA CELL LINES (1987) (0)
- In vitro antiviral activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2 (1993) (0)
- Hybrid peptides for the treatment of Bacteremia and sepsis (2002) (0)
- Peptides, used as a carrier in immunogenic constructs which are useful in the development of synthetic vaccines (1995) (0)
- Interferon and interleukin-derivatives with long-term effect, and compositions containing them, pharmaceutical (2001) (0)
- Long-acting medicaments and pharmaceutical compositions comprising these (1997) (0)
- POLYMERIC REAGENTS IN PEPTIDE SYNTHESIS (75 LITERATURANGABEN) (1981) (0)
- Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein. (1996) (0)
- Medicaments a absorption orale (2002) (0)
- Neuropeptides and skin cell function: VIP and stearyl-[Nle17]VIP effects on HaCaT cells (2002) (0)
- INVOLVEMENT OF TRYPTOPHAN IN THE BINDING SITE OF THE B PROTOMER OF CHOLERA TOXIN (1981) (0)
- ANTIBODIES TO SYNTHETIC PEPTIDES AS PROBES FOR THE a-SUBUNIT AND FOR THE CHOLINERGIC BINDING SITE OF THE ACETYLCHOLINE RECEPTOR (1985) (0)
- Tumor-associated antigen peptides as anti-metastatic vaccines (1998) (0)
- mechanism to enhance glucose metabolism Vanadate restores glucose 6-phosphate in diabetic rats: a (2016) (0)
- Authors' Reply (2009) (0)
- Synthesis and biological activity of [L-hydroxyproline]3-tuftsin analogue and its alpha- or beta-O-D-glucosylated derivatives. (1993) (0)
- P277 peptide analogs and pharmaceutical compositions containing them for the treatment of diabetes and diagnosis (1997) (0)
- Volumetric determination of amino acid and peptide hydrazides (1970) (0)
- Effect of O-Glycosylation on the Bioactivity of Tuftsin, (1992) (0)
- 36 Gene and peptide therapy of tumor metastases in murine models (1995) (0)
- VIP conjugates and their active fragments having hydrophobic moieties and topical Zuberetungen for use in the treatment of male impotence. (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Matityahu M. Fridkin?
Matityahu M. Fridkin is affiliated with the following schools:
